Evaluation of a Novel Boron-Containing α-<span style="font-variant: small-caps">d</span>-Mannopyranoside for BNCT

Boron neutron capture therapy (BNCT) is a unique anticancer technology that has demonstrated its efficacy in numerous phase I/II clinical trials with boronophenylalanine (BPA) and sodium borocaptate (BSH) used as ¹⁰B delivery agents. However, continuous drug administration at high concent...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Takao Tsurubuchi, Makoto Shirakawa, Wataru Kurosawa, Kayo Matsumoto, Risa Ubagai, Hiroshi Umishio, Yasuyo Suga, Junko Yamazaki, Akihiro Arakawa, Yutaka Maruyama, Takuya Seki, Yusuke Shibui, Fumiyo Yoshida, Alexander Zaboronok, Minoru Suzuki, Yoshinori Sakurai, Hiroki Tanaka, Kei Nakai, Eiichi Ishikawa, Akira Matsumura
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2020-05-01
Edice:	Cells
Témata:	boron-containing α-<span style="font-variant: small-caps">d</span>-mannopyranoside closo-dodecarborate low-molecular-weight compound BNCT
On-line přístup:	https://www.mdpi.com/2073-4409/9/5/1277
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!